Registry Study of Thoracic Reirradiation for Non-Small Cell Lung Cancer (NSCLC) Utilizing Proton Beam Therapy or Intensity Modulated Radiation Therapy

Completed

Conditions studied: Non-Small Cell Lung Cancer

In brief

The goal of this research study is to learn more about the safety of treating NSCLC with reirradiation using standard methods and to look for ways to lessen side effects and improve therapy. Reirradiation is when radiation is given to an area of the body that has previously received a full dose of radiation.

Key facts

Study ID

NCT01808677

Run by

M.D. Anderson Cancer Center

People needed

49

Starts

2012-06-01

Expected to finish

2016-08-01

Last updated by the study team

2016-08-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• History of previous histologically or cytologically documented NSCLC, stage I-IV.
• Prior course of radiation therapy or concurrent chemoradiation at least 1 month prior to the current course of radiation therapy.
• Patients eligible to receive a second course of radiation therapy to the thorax, at the discretion of the treating physician.
• Patients receiving concurrent chemotherapy or targeted agents will be eligible for this protocol.
• 2 Exclusion Criteria:
• Life expectancy<3 months
• Pregnancy.

Where it is running

• University of Texas MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.